Cited Reference

1. Green WR, Chan CC, Hutchins GM, Terry JM et al. Central retinal vein 
occlusions: A prospective histopathologic study of 29 eyes in 28 cases. Retina 1981; 1: 27-55.

2. Green WR . Retina. In Spencer WH (Ed): Ophthalmic pathology. An Atlas and Textbook. 3rd Ed. Philadephia. WB Saunders. 1985; p589.

3. Frangieh GT, Green WR, Barraquer-Soers E et al. Histopathologic study of nine branch
retinal vein occlusions. Arch Ophthalmol 1982; 100: 1132-40 .

4. Orth DH, Patz A. Retinal branch vein occlusion. Surv Ophthalmol 1978; 22: 357-376 .

5. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984; 15;98(3):271-82.

6. Branch Vein Occlusion Study Group Argon laser scatter photocoagulation fo prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 1986;104:34-41.

7. Mitchell, P., Smith, W., and Chang, A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch-Ophthalmol 1996; 114:1243-7.

8. Dodson, P. M and Kritzinger, E. E. Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997? Eye 1997;11: 3-11.

9. Dodson, P. M., Kritzinger, E. E., Clough, C. G., Diabetes mellitus and retinal vein occlusion in patients of Asian, West Indian and White European origin. Eye 1992; 6: 66-68.

10. The Eye Disorders Case-Control Study Group Risk Factors for Central Retinal Vein Occlusion. Arch Ophthalmol 1996; 114: 545-54.

11. Dodson, P M, Galton, D J, Hamilton, AM et al. Retinal Vein Occlusion and the Prevalence of Lipoprotein Abnormalities. Br J Ophthalmol 1982; 66: 161-164.

12. The Eye Disease Case-Control Study Group Risk Factors for Branch Retinal Vein Occlusion. Am J Ophthalmol 1993; 116: 286-96.

13. Elman MJ, Bhatt AK, Quinlan PM, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 1990;97(11):1543-8.

14. Hirota, A., Mishima, H. K., and Kiuchi, Y. Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University. Ophthalmologica 1997; 211: 288-91.

15. Fegan, C. D. Central retinal vein occlusion and thrombophilia. Eye 2002; 11: 98-106.

16. Kirwan, J. F., Tsaloumas, M. D., Vinall, H., Prior, P., Kritzinger, E. E., Dodson, P. M. Sex hormone preparations and retinal vein occlusion. Eye 1997; 11:53-56.

17. Dodson, P M and Kritzinger, E E. Underlying Medical Conditions in Young Patients and Ethnic Differences in Retinal Vein Occlusion. Trans Ophthalmol Soc UK 1985; 104:114-119.

18. The Central Vein Occlusion Study Group A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: The Central Retinal Vein Occlusion Study Group N Report. Ophthalmology 1995;102: 1434-44.

19. Sabates R, Hirose T, McMeel JW. Electrophysiology in the prognosis and classification of central retinal vein occlusion. Arch Ophthalmol 1983; 101:232-235 .

20. Hayreh SS, Klugman MR, Podhajsky P et al. Electroretinography in central retinal vein occlusion. Correlation of electro-retinographic changes with pupillary abnormalities. Graefes Arch Clin Exp Ophthalmol 1989; 227:549-561.

21. Breton ME, Quinn GE, Keene SS et al. Electroretinogram parameters at presentation as predictors of rubeosis in CRVO patients. Ophthalmology 1989: 96: 1343-1352 .

22. Kay SB, Harding SP. Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis. Arch Ophthalmol 1988; 106: 353- 6 .

23. Bresnick GH. Following up patients with central retinal vein occlusion. Arch Ophthalmol 1988; 106:324- 6 .

24. Hayreh SS, Rojas P, Podhajsky P et al: Ocular neovascularisation with retinal vascular occlusion. III. Incidence of ocular neovascularisation with retinal vein occlusion. Ophthalmology 1983; 90: 488-506.

25. Quinlan PM, Elman MJ, Kaur Bhatt A et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990; 110: 118-123.

26. Miturn J, Brown GC. Progression of nonischemic central retinal vein obstruction to the ischemic variant. Ophthalmology 1986;93:1158-1162.

27. Central Retinal Vein Occlusion Study Group. Natural history and 
clinical management of central retinal vein occlusion. Arch Ophthalmol 1997; 115: 486-491.

28. Laatikainen, L. A prospective follow-up study of panretinal photocagulation in preventing neovascular glaucoma following ischaemic central retinal vein occlusion. Graefe’s Arch Clin Exp Ophthalmol 1983; 220:236-239.

29. Murdoch I E, Rosen PH, Shilling JS. Neovascular response in ischaemic CRVO after panretinal photocoagulation. Br J Ophthalmol 1991; 75:459-61.

30. Hayreh S S , Klugman, MR, Podhajsky, P,Servais, GE, Perkins, ES. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. Graefe’s Arch Clin Exp Ophthalmol 1990; 78:281-296.

31. Evans K, Wishart PK, McGalliard JN. Neovascular complications after central retinal vein occlusion. Eye 1993; 7:520-524.

32. The Central Vein Occlusion Study Group. Evaluation of grid pattern
photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995;102:1425-33.

33. Eccarius SG, Moran MJ, Slingby JG. Choroidal neovascular membrane after laserinduced chorioretinal anastomosis. Am J Ophthalmol 1996; 122:590-1.

34. Luttrull JK. Epiretinal membrane and traction retinal detachment complicating laserinduced chorioretinal venous anastomosis. Am J Ophthalmol 1997;123: 698-9.

35. Browning DJ, Rotberg MH. Vitreous hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion. Am J Ophthalmol 1996;122:588-9.

36. Shilling JS, Kohner EM. New vessel formation in retinal branch vein occlusion.Br J Ophthalmol 1976;60: 810-5.

37. Shilling, JS, Jones, CA. Retinal branch vein occlusion: A study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 1984; 68: 196-198.

38. Finkelstein D. Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology 1986; 93:975-977.

39. Hayreh SS, Hayreh MS. Hemi-central retinal vein occlusion. Pathogenesis, clinical features and natural history. Arch Ophthalmol 1980; 98:1600-9 .

40. Hayreh S S, Zimmerman M B, Podhajski P. Incidence of various types of retinal vein occlusion and the recurrence and demographic characteristics. Am J. Ophthalmol 1994; 117: 429-441.

41. Rubinstein K, Jones B. Retinal vein occlusion: long term prospects, 10 years follow-up of 143 patients. Br. J. Ophthalmol 1976; 60; 148-150.

42. Tsaloumas M D, Kirwan, J, Vinall, H., O’Leary M B, Prior P, Kritzinger E E, Dodson P M. Nine year follow up study of morbidity and mortality in retinal vein occlusion. Eye 2000;14: 821-827.

43. Gass JD. Stereoscopic Atlas of Macular Diseases. C V Mosby 1997; Vol I: 548

44. Joint British Recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart 1998; 80 (suppl 2): S1-329.

45. Martin SC, Butcher A, Martin N, Farmer J, Bartlett WA, Jones A F, Dodson P M. Cardiovascular risk assessment in patients with retinal vein occlusion. Br. J. Ophthalmol 2002;86:774-776.

46. Petitti DB. Hormone replacement therapy for prevention: more evidence, more pessimism. JAMA 2002; 288: 99-101.

47. Fong ACO, Shatz H. Central retinal vein occlusion in young adults. Surv. Ophthalmol 1993; 37:393-417.

48. Bayly GR, Bartlett WA, Davies PH et al Laboratory based calculation of coronary heart disease risk in a hospital diabetic clinic. Diab Med 1999; 16: 697-701.

49. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, McGThom S. Guidelines for the management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS 1V. J. Human Hypertension 2004;18: 137-185.

Introduction Methods used Risk factors CRVO
BRVO Medical treatment Cardiovascular problems Young patient
References. Tables Main index Main page.